PolyActiva’s platform technology is used to deliver drugs to specific sites in the body with control over the rate of drug delivery for up to 12-months. The technology involves formation of a polymeric prodrug of the target drug, which in turn is the sole component used to produce the administered product. The product administered to the site can take various forms, including rod-shaped implants, injectable gels, and topical...
PolyActiva’s platform technology is used to deliver drugs to specific sites in the body with control over the rate of drug delivery for up to 12-months. The technology involves formation of a polymeric prodrug of the target drug, which in turn is the sole component used to produce the administered product. The product administered to the site can take various forms, including rod-shaped implants, injectable gels, and topical film. The company began operation in February 2010 and since its formation has secured in excess of $26 million of investment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.